137 related articles for article (PubMed ID: 10065898)
1. In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016.
Wallace JL; Muscara MN; McKnight W; Dicay M; Del Soldato P; Cirino G
Thromb Res; 1999 Jan; 93(1):43-50. PubMed ID: 10065898
[No Abstract] [Full Text] [Related]
2. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
3. Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats.
Muscará MN; Lovren F; McKnight W; Dicay M; del Soldato P; Triggle CR; Wallace JL
Br J Pharmacol; 2001 Aug; 133(8):1314-22. PubMed ID: 11498517
[TBL] [Abstract][Full Text] [Related]
4. The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat.
Rossoni G; Manfredi B; Colonna VD; Bernareggi M; Berti F
J Pharmacol Exp Ther; 2001 Apr; 297(1):380-7. PubMed ID: 11259566
[TBL] [Abstract][Full Text] [Related]
5. NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide.
Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Morelli A; del Soldato P; Minuz P
Circulation; 2002 Dec; 106(24):3120-5. PubMed ID: 12473561
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of ticlopidine and aspirin, administered alone and in combination, on thrombus formation in rat cerebral vessels.
Sasaki Y; Ishii I; Giddings JC; Yamamoto J
Haemostasis; 1996; 26(3):150-6. PubMed ID: 8738589
[TBL] [Abstract][Full Text] [Related]
7. Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin.
Momi S; Emerson M; Paul W; Leone M; Mezzasoma AM; Del Soldato P; Page CP; Gresele P
Eur J Pharmacol; 2000 May; 397(1):177-85. PubMed ID: 10844112
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
Antoniades C; Tousoulis D; Stefanadis C
Int J Cardiol; 2007 May; 118(2):170-2. PubMed ID: 16997401
[TBL] [Abstract][Full Text] [Related]
9. Unusual effects of aspirin on ticlopidine induced thrombolysis.
Gryglewski RJ; Uracz W; Swieş J
Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S17-9. PubMed ID: 10992548
[No Abstract] [Full Text] [Related]
10. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Gresele P; Momi S
Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
[TBL] [Abstract][Full Text] [Related]
12. Flurbinitroxybutylester: a novel anti-inflammatory drug has enhanced antithrombotic activity.
Cirino G; Cicala C; Mancuso F; Baydoun AR; Wallace JL
Thromb Res; 1995 Jul; 79(1):73-81. PubMed ID: 7495106
[TBL] [Abstract][Full Text] [Related]
13. Reduction of shock-induced gastric damage by a nitric oxide-releasing aspirin derivative: role of neutrophils.
Wallace JL; McKnight W; Wilson TL; Del Soldato P; Cirino G
Am J Physiol; 1997 Dec; 273(6):G1246-51. PubMed ID: 9435549
[TBL] [Abstract][Full Text] [Related]
14. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
15. Combining aspirin with antithrombotic agents.
Sung JJ
BMJ; 2006 Oct; 333(7571):712-3. PubMed ID: 17023437
[No Abstract] [Full Text] [Related]
16. Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Ueno Y; Kawashima A; Koike H; Nishio S
Thromb Res; 1995 Jan; 77(2):193-8. PubMed ID: 7740511
[No Abstract] [Full Text] [Related]
17. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp).
Liu Y; Luo W; Yang H; Fang W; Xi T; Li Y; Xiong J
Thromb Res; 2015 Aug; 136(2):319-27. PubMed ID: 26028472
[TBL] [Abstract][Full Text] [Related]
20. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
Gresele P; Migliacci R; Procacci A; De Monte P; Bonizzoni E
Thromb Haemost; 2007 Mar; 97(3):444-50. PubMed ID: 17334512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
